SAMPLE6

sample6-logo

Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours. Its proprietary Bioillumination Platform was developed by Professor Tim Lu (MIT) and Dr. Michael Koeris in the lab of Professor James Collins at the Howard Hughes Medical Institute and Boston University. The platform allows for the engineering of bioparticles that target and “light up” specific unwanted bacteria—or specific groups... of bacterial species. They couple this capability with highly sensitive sensor technology that detects low levels of pathogens to see results in minutes—right on-site—with no laboratory required. Sample6′s mission is to improve the health and safety of global consumers by building integrated systems that quickly and easily detect harmful and unwanted bacteria. They see applications in food production, retailing, healthcare, and beyond—anywhere humans and bacteria intersect.

#SimilarOrganizations #People #Financial #Website #More

SAMPLE6

Social Links:

Industry:
Biotechnology Health Diagnostics Medical Sensor

Founded:
2009-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.phagediagnostics.com

Total Employee:
11+

Status:
Active

Contact:
617-393-7600

Email Addresses:
[email protected]

Total Funding:
41.7 M USD

Technology used in webpage:
SPF Amazon Virginia Region SingleHop


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

remedy-plan-therapeutics-logo

Remedy Plan Therapeutics

Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.


Current Advisors List

stephen-bloch_image

Stephen Bloch Board Member @ Sample6
Board_member

micah-rosenbloom_image

Micah Rosenbloom Board Member @ Sample6
Board_member
2013-03-01

sam-kass_image

Sam Kass Board of Directors @ Sample6
Board_member

jeff-bussgang_image

Jeff Bussgang Member of the Board of Directors @ Sample6
Board_member
2014-03-01

Current Employees Featured

jim-hammel_image

Jim Hammel
Jim Hammel Vice President, Customer Success @ Sample6
Vice President, Customer Success

michael-koeris_image

Michael Koeris
Michael Koeris CEO @ Sample6
CEO

timothy-k-lu_image

Timothy K. Lu
Timothy K. Lu Co-Founder, Director @ Sample6
Co-Founder, Director

Founder


michael-koeris_image

Michael Koeris

tanguy-chau_image

Tanguy Chau

timothy-k-lu_image

Timothy K. Lu

not_available_image

Timothy Lu

Investors List

acre-venture-partners_image

Acre Venture Partners

Acre Venture Partners investment in Series C - Sample6

valley-oak-investment_image

Valley Oak Investments

Valley Oak Investments investment in Series C - Sample6

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series C - Sample6

cultivian-sandbox-ventures_image

Cultivian Sandbox Ventures

Cultivian Sandbox Ventures investment in Series C - Sample6

timothy-k-lu_image

Timothy K. Lu

Timothy K. Lu investment in Series B - Sample6

flybridge-capital_image

Flybridge

Flybridge investment in Series B - Sample6

flybridge-capital_image

Flybridge

Flybridge investment in Series B - Sample6

chevron-technology-ventures_image

Chevron Technology Ventures

Chevron Technology Ventures investment in Series B - Sample6

cultivian-sandbox-ventures_image

Cultivian Sandbox Ventures

Cultivian Sandbox Ventures investment in Series B - Sample6

founder-collective_image

Founder Collective

Founder Collective investment in Series B - Sample6

Official Site Inspections

http://www.phagediagnostics.com

  • Host name: server.iehlabs.com
  • IP address: 96.127.129.194
  • Location: Chicago United States
  • Latitude: 41.8777
  • Longitude: -87.6376
  • Metro Code: 602
  • Timezone: America/Chicago
  • Postal: 60604

Loading ...

More informations about "Sample6"

Phage Canada

Phage Canada began informally in 2020 to connect those working on, or interested in, phage research and applications in Canada.See details»

Phages as diagnostic tools - Phage Directory

Apr 25, 2019 · In this article, I highlight three FDA-approved or available products for phage-mediated detection of bacterial pathogens in the agricultural, clinical and biodefense …See details»

Phage-based platforms for the clinical detection of human …

In this review, we focus on the four bacterial pathogens whereby phage-based diagnostics are currently in use, FDA-approved, or a product is available for the detection of clinical isolates; …See details»

6 Phage Companies Worldwide | Biotech Careers

View the list and locations of 6 biotechnology companies engaged in Phage work.See details»

Detect Brochure Adjusted - Phage Diagnostics

Sample6 DETECT is an on-site in-shift pathogen diagnostic. This advancement paired with powerful analytics from Sample6 CONTROL will shift food safety from reaction to prevention. …See details»

Sample6 - Crunchbase Company Profile & Funding

Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours. Its proprietary …See details»

Advances in the Development of Phage-Based Probes for …

Jan 7, 2022 · Bacteriophages, abbreviated as “phages”, have been developed as emerging nanoprobes for the detection of a wide variety of biological species, such as biomarker …See details»

Phage Display to Detect and Identify Autoantibodies in Disease

Jul 3, 2019 · Both Smith and Winter used bacteriophage (phage) display to identify peptides and antibodies that are now being used in the diagnosis and treatment of diseases, including …See details»

PHASTEST

PHASTEST now offers a much more responsive, interactive visualization interface that allows users to generate, edit, annotate and interactively visualize (zooming, rotating, dragging, …See details»

Unlocking the potential of phages: Innovative approaches to …

Phages, viruses that infect bacteria, have been explored as promising tools for the detection of human disease. By leveraging the specificity of phages for their bacterial hosts, phage-based …See details»

Phage-based platforms for the clinical detection of human …

Apr 1, 2012 · In this review, we focus on the four bacterial pathogens whereby phage-based diagnostics are currently in use, FDA-approved, or a product is available for the detection of …See details»

The Application of Bacteriophage Diagnostics for Bacterial …

Dec 16, 2020 · Phage diagnostics have been proven to be rapid, capable of identifying viable pathogens and do not require cultivation to detect bacteria. Phage detection takes advantage …See details»

Phage-based platforms for the clinical detection of human …

Apr 1, 2012 · We briefly describe the disease, the current diagnostic options, and the role phage diagnostics play in identifying the cause of infection, and determining antibiotic susceptibility. …See details»

Phage-layer interferometry: a companion diagnostic for phage …

Mar 12, 2024 · In practice, phage therapy is personalized and requires companion diagnostics to identify efficacious phages, which are then formulated into a therapeutic cocktail.See details»

What the Phage: a scalable workflow for the identification and …

Nov 18, 2022 · Phage prediction from sequence data is a crucial first step to understanding their impact on the environment. A variety of bacteriophage prediction tools have been developed …See details»

Phage immunoprecipitation sequencing - Insights

Sep 14, 2022 · One example of these innovations is the use of phage immunoprecipitation sequencing to discover new serological biomarkers for autoimmune diseases. This approach …See details»

High throughput platform technology for rapid target ... - Nature

Jul 11, 2024 · We demonstrate high throughput screening by identifying target phages for select multidrug-resistant clinical isolates of Pseudomonas aeruginosa, Salmonella enterica, …See details»

Exploiting Bacteriophage as a Diagnostic Tool

Apr 29, 2022 · PBD Biotech has developed a diagnostic test for TB that leverages bacteriophage technology alongside qPCR to identify live, disease-causing pathogens in humans and cattle.See details»

Phage display as a tool for vaccine and immunotherapy …

Phages are heavily utilized in bioengineering for applications ranging from tissue engineering scaffolds to immune signal delivery. Of specific interest to vaccines and immunotherapies, …See details»

Frontiers | Rapid hydrogel-based phage susceptibility test for ...

Dec 6, 2022 · With the help of fast and high throughput phage screening methods, routine phage diagnostics can be done efficiently (Henry et al., 2012; Rajnovic et al., 2019). In this study, we …See details»

linkstock.net © 2022. All rights reserved